Stempel David A, Kaye Leanne, Bender Bruce G
Consultant in Digital Health, Bellevue, Wash.
ResMed, San Francisco, Calif.
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4239-4242. doi: 10.1016/j.jaip.2021.07.034. Epub 2021 Aug 2.
Adherence to prescribed medications for chronic respiratory disease is considered a keystone for successful management. There is little consensus, though, on how to measure adherence, what is optimal adherence, or the goals of appropriate medication utilization. These criteria may differ when studying medication utilization at the patient or population level. The role of consistent medication use in chronic respiratory disease is associated with better outcomes. Shared decision-making is one strategy to achieve appropriate levels of adherence that requires negotiation, compromise by both patient and provider. It also recognizes that both success and failure to achieve goals of adherence are shared. As such, we discuss the current understanding of adherence measures in respiratory disease and identify the need for more nuanced approaches to evaluate adherence to reach acceptable patient outcomes.
坚持服用慢性呼吸道疾病的处方药被认为是成功治疗的关键。然而,对于如何衡量依从性、最佳依从性是什么,或者合理用药的目标,几乎没有共识。在患者或人群层面研究药物使用情况时,这些标准可能会有所不同。在慢性呼吸道疾病中持续用药的作用与更好的治疗效果相关。共同决策是实现适当依从水平的一种策略,这需要患者和医疗服务提供者进行协商和妥协。它还认识到实现依从目标的成功与失败是共同的。因此,我们讨论了目前对呼吸道疾病依从性测量的理解,并确定需要更细致入微的方法来评估依从性,以实现可接受的患者治疗效果。